Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Improving treatment of pancreatic cancer.

× No keyword cloud information.

8 in total

1. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1.

Authors: Davide Melisi; Qianghua Xia; Genni Paradiso; Jianhua Ling; Tania Moccia; Carmine Carbone; Alfredo Budillon; James L Abbruzzese; Paul J Chiao
Journal: J Natl Cancer Inst Date: 2011-07-08 Impact factor: 13.506

Review 2. Specificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancer.

Authors: Darshil T Jhaveri; Lei Zheng; Elizabeth M Jaffee
Journal: Semin Oncol Date: 2014-07-22 Impact factor: 4.929

3. Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205.

Authors: Philip A Philip; Jacqueline Benedetti; Christopher L Corless; Ralph Wong; Eileen M O'Reilly; Patrick J Flynn; Kendrith M Rowland; James N Atkins; Barry C Mirtsching; Saul E Rivkin; Alok A Khorana; Bryan Goldman; Cecilia M Fenoglio-Preiser; James L Abbruzzese; Charles D Blanke
Journal: J Clin Oncol Date: 2010-07-06 Impact factor: 44.544

Review 4. Adjuvant and neoadjuvant treatment in pancreatic cancer.

Authors: Marta Herreros-Villanueva; Elizabeth Hijona; Angel Cosme; Luis Bujanda
Journal: World J Gastroenterol Date: 2012-04-14 Impact factor: 5.742

5. Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma.

Authors: Hailiang Liu; Yong Xu; Kai Liang; Rong Liu
Journal: Front Oncol Date: 2020-08-21 Impact factor: 6.244

6. Lithium inhibits tumorigenic potential of PDA cells through targeting hedgehog-GLI signaling pathway.

Authors: Zhonglu Peng; Zhengyu Ji; Fang Mei; Meiling Lu; Yu Ou; Xiaodong Cheng
Journal: PLoS One Date: 2013-04-23 Impact factor: 3.240

Review 7. Current immunotherapeutic approaches in pancreatic cancer.

Authors: Shigeo Koido; Sadamu Homma; Akitaka Takahara; Yoshihisa Namiki; Shintaro Tsukinaga; Jimi Mitobe; Shunichi Odahara; Toyokazu Yukawa; Hiroshi Matsudaira; Keisuke Nagatsuma; Kan Uchiyama; Kenichi Satoh; Masaki Ito; Hideo Komita; Hiroshi Arakawa; Toshifumi Ohkusa; Jianlin Gong; Hisao Tajiri
Journal: Clin Dev Immunol Date: 2011-09-14

8. Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma.

Authors: Guang-Jun Li; Hong-Wei Xu; Juan-Juan Ji; Fang Yang; Bao-Qin Gao
Journal: Onco Targets Ther Date: 2016-03-01 Impact factor: 4.147

8 in total